• LG 101506: An RXR Modulator for Mechanistic Research

  2026-09-03

  LG 101506 is an RXR modulator for dissecting nuclear receptor signaling, transcriptional control, and metabolism regulation. This article develops a careful assay framework that connects RXR signaling pathway research with, but does not overstate, mechanistic lessons from TNBC immune-checkpoint biology.

• Tetrandrine: Calcium Channel Research Guide

  2026-09-03

  Tetrandrine is a bioactive Tetrandrine alkaloid used as a calcium-channel-modulating research compound. Its defined identity, DMSO handling profile, and evidence boundaries support controlled ion channel modulation studies, inflammation research, neuroscience research, and cancer biology research without implying clinical efficacy.

• Gentamycin Sulfate: Resistance Research Workflows

  2026-09-02

  Use Gentamycin Sulfate as both a bacterial protein synthesis probe and a phenotype anchor for Gram-negative resistance studies. This workflow connects 30S ribosome inhibition with susceptibility testing, plasmid transfer, and carbapenemase-gene surveillance without treating one MIC result as a complete transmission model.

• BHA Workflows for Oxidative Stress Research

  2026-09-02

  Build cleaner oxidative stress experiments with BHA by controlling solvent, exposure time, concentration, and orthogonal readouts. This practical guide adapts lessons from peptide pharmacology to ROS detection, cellular protection, apoptosis interpretation, and inflammation research without overstating what the reference evidence proves.

• SLC25A1, Senescence, and Cisplatin Resistance in HNSCC

  2026-09-01

  The reference study identifies SLC25A1 as a metabolic and epigenetic regulator of cisplatin resistance in head and neck squamous cell carcinoma, linking citrate transport and cytosolic acetyl-CoA to H3K27ac-dependent senescence programs. Its findings position SLC25A1 as a candidate biomarker and therapeutic target, while also emphasizing the need for orthogonal validation of senescence phenotypes.

• PKH26 Red Fluorescent Cell Linker Kit Guide

  2026-09-01

  The PKH26 Red Fluorescent Cell Linker Kit provides red fluorescent labeling of cell membrane lipid regions for longitudinal cell tracing and proliferation-oriented assays. It is intended for membrane labeling in vitro or in vivo, not for intracellular targets, non-membrane labeling, or interpreting fluorescence as a standalone viability or cell-identity marker.

• Sulfaphenazole in CYP2C9 and Vascular Research

  2026-08-31

  Sulfaphenazole combines selective CYP2C9 inhibition with antibacterial activity, making it useful for both drug-metabolism assays and oxidative-stress-sensitive vascular models. This practical guide covers concentration selection, endothelial workflows, formulation, controls, and troubleshooting.

• Caged Bioluminescent Probe for Immunoproteasome Activity

  2026-08-31

  Loy and Trader describe a cleavable, peptide-based bioluminescent activity probe designed to monitor the β5i catalytic subunit of the immunoproteasome. By combining immunoproteasome-selective recognition with aminoluciferin release and plate-reader detection, the protocol provides a practical route for cellular activity assays and supports future development of disease-relevant imaging workflows.

• Erastin Ferroptosis Workflows for Cancer Biology

  2026-08-30

  Erastin is a practical ferroptosis inducer for connecting RAS/BRAF genotype with oxidative cell death, using controllable small-molecule exposure rather than receptor-targeted delivery. This guide covers assay design, reference-informed readouts, dosing, storage, and troubleshooting for reproducible cancer biology research.

• CX-5461 Drives Mitotic Catastrophe in Cervical Cancer

  2026-08-29

  The June 2026 reference study identifies a mechanism by which the RNA polymerase I inhibitor CX-5461 suppresses cervical cancer cell growth: DNA damage activates ATM/ATR signaling, while Cyclin B1–CDK1 dysregulation forces damaged cells into mitosis and mitotic catastrophe. The study also shows enhanced cisplatin sensitivity, providing a mechanistic rationale for investigating Pol I inhibition in primary and platinum-resistant cervical cancer models.

• L1023 Anti-Cancer Compound Library | PLAC1

  2026-08-28

  Explore how the L1023 Anti-Cancer Compound Library can support phenotype-to-mechanism discovery in oncology. Using PLAC1-driven clear cell renal cell carcinoma research as a case study, this guide connects chemical screening, pathway analysis, and orthogonal validation.

• PPARγ, Macrophage Polarization, and DSS-Induced IBD

  2026-08-28

  This study identifies PPARγ activation as a regulator of macrophage polarization in DSS-induced intestinal inflammation, linking reduced STAT-1 signaling and enhanced STAT-6 signaling to improved disease and barrier outcomes. Its design provides a useful framework for studying PPARγ-dependent immunometabolism, while the absence of antagonist experiments limits direct translation to inhibitor-based workflows.

• Ziprasidone Augmentation in Anxious Depression

  2026-08-27

  This post-hoc moderator analysis examined whether baseline anxious depression changed the effects of ziprasidone added to escitalopram, using depression and anxiety rating-scale outcomes from a randomized controlled trial. The study found comparable antidepressant improvement across anxiety subgroups, while the apparent anxiety benefit in patients with greater baseline anxiety was not clinically significant, highlighting the importance of phenotype-aware interpretation in augmentation research.

• Neuroligin 1 Proteolysis Maintains Social Memory

  2026-08-27

  Liu et al. identify a proteolytic mechanism that converts social experience into a persistent intracellular signal in the ventral hippocampus. Their evidence indicates that the NLG1-CTD fragment, acting through its PDZ-binding domain and cofilin signaling, supports spine maturation and short-term social-memory maintenance.

• Rotavirus Infection and Nrf2 Redox Defense

  2026-08-26

  The reference study shows that rotavirus infection produces a biphasic Nrf2 response: an early, redox-sensitive increase is followed by pronounced Nrf2 depletion and suppression of antioxidant genes. Its mechanistic experiments indicate that late loss of Nrf2 is not adequately explained by canonical Keap1–Cul3 turnover, but is associated with proteasome-sensitive, K48-linked ubiquitination.

8381 records 1/559 page Next 12345 下5页 Last page